UB Paderborn / Katalog / Suche / in CDI

Leptin in Leanness and Obesity: JACC State-of-the-Art Review

Journal of the American College of Cardiology, 2021-02, Vol.77 (6), p.745-760

2021

Link zum Volltext

Verfügbarkeit prüfen

The role of leptin in regulating bone metabolism

Metabolism, clinical and experimental, 2015-01, Vol.64 (1), p.105-113

2015

Link zum Volltext

Verfügbarkeit prüfen

Pharmacotherapy of obesity: Available medications and drugs under investigation

Metabolism, clinical and experimental, 2019-03, Vol.92, p.170-192

2019

Link zum Volltext

Verfügbarkeit prüfen

Metabolic health and weight: Understanding metabolically unhealthy normal weight or metabolically healthy obese patients

Metabolism, clinical and experimental, 2016-01, Vol.65 (1), p.73-80

2016

Link zum Volltext

Verfügbarkeit prüfen

Leptin alters energy intake and fat mass but not energy expenditure in lean subjects

Nature communications, 2020-10, Vol.11 (1), p.5145-5145, Article 5145

2020

Link zum Volltext

Verfügbarkeit prüfen

Leptin and the brain: Influences on brain development, cognitive functioning and psychiatric disorders

Metabolism, clinical and experimental, 2015-01, Vol.64 (1), p.114-130

2015

Link zum Volltext

Verfügbarkeit prüfen

Leptin applications in 2015: what have we learned about leptin and obesity?

Current opinion in endocrinology, diabetes, and obesity, 2015-10, Vol.22 (5), p.353-359

2015

Link zum Volltext

Verfügbarkeit prüfen

Central nervous system regulation of eating: insights from human brain imaging

Metabolism, clinical and experimental, 2016-05, Vol.65 (5), p.699-713

2016

Link zum Volltext

Verfügbarkeit prüfen

Acute diet soda consumption alters brain responses to food cues in humans: A randomized, controlled, cross-over pilot study

Nutrition and health (Berkhamsted), 2021-10, Vol.27 (3), p.295-299

Farr, Olivia M.

2021

Link zum Volltext

Verfügbarkeit prüfen

Fasting oxyntomodulin, glicentin, and gastric inhibitory polypeptide levels are associated with activation of reward‐ and attention‐related brain centres in response to visual food cues in adults with obesity: A cross‐sectional functional MRI study

Diabetes, obesity & metabolism, 2021-05, Vol.23 (5), p.1202-1207

2021

Link zum Volltext

Verfügbarkeit prüfen

Decreased saliency processing as a neural measure of Barratt impulsivity in healthy adults

NeuroImage (Orlando, Fla.), 2012-11, Vol.63 (3), p.1070-1077

2012

Link zum Volltext

Verfügbarkeit prüfen

Leptin in congenital and HIV-associated lipodystrophy

Metabolism, clinical and experimental, 2015, Vol.64 (1), p.47-59

2015

Link zum Volltext

Verfügbarkeit prüfen

Short-term treatment with high dose liraglutide improves lipid and lipoprotein profile and changes hormonal mediators of lipid metabolism in obese patients with no overt type 2 diabetes mellitus: a randomized, placebo-controlled, cross-over, double-blind clinical trial

Cardiovascular diabetology, 2019-10, Vol.18 (1), p.141-141, Article 141

2019

Link zum Volltext

Verfügbarkeit prüfen

Branched-Chain Amino Acids in relation to food preferences and insulin resistance in obese subjects consuming walnuts: A cross-over, randomized, double-blind, placebo-controlled inpatient physiology study

Clinical nutrition (Edinburgh, Scotland), 2021-05, Vol.40 (5), p.3032-3036

2021

Link zum Volltext

Verfügbarkeit prüfen

GEOFFREY HARRIS PRIZE LECTURE 2018: Novel pathways regulating neuroendocrine function, energy homeostasis and metabolism in humans

European journal of endocrinology, 2019-02, Vol.180 (2), p.R59

2019

Link zum Volltext

Verfügbarkeit prüfen

Old and new tools to study human brain physiology: Current state, future directions and implications for metabolic regulation

Metabolism, clinical and experimental, 2019-10, Vol.99, p.iii-viii

2019

Link zum Volltext

Verfügbarkeit prüfen

Of mice and men: incretin actions in the central nervous system

Metabolism, clinical and experimental, 2019-09, Vol.98, p.121-135

2019

Link zum Volltext

Verfügbarkeit prüfen

Short-term administration of the GLP-1 analog liraglutide decreases circulating leptin and increases GIP levels and these changes are associated with alterations in CNS responses to food cues: A randomized, placebo-controlled, crossover study

Metabolism, clinical and experimental, 2016-07, Vol.65 (7), p.945-953

2016

Link zum Volltext

Verfügbarkeit prüfen

Lorcaserin treatment decreases body weight and reduces cardiometabolic risk factors in obese adults: A six‐month, randomized, placebo‐controlled, double‐blind clinical trial

Diabetes, obesity & metabolism, 2019-06, Vol.21 (6), p.1487-1492

2019

Link zum Volltext

Verfügbarkeit prüfen

Lorcaserin Administration Decreases Activation of Brain Centers in Response to Food Cues and These Emotion- and Salience-Related Changes Correlate With Weight Loss Effects: A 4-Week-Long Randomized, Placebo-Controlled, Double-Blind Clinical Trial

Diabetes (New York, N.Y.), 2016-10, Vol.65 (10), p.2943-2953

2016

Link zum Volltext

Verfügbarkeit prüfen

Obese individuals with type 2 diabetes demonstrate decreased activation of the salience‐related insula and increased activation of the emotion/salience‐related amygdala to visual food cues compared to non‐obese individuals with diabetes: A preliminary study

Diabetes, obesity & metabolism, 2018-10, Vol.20 (10), p.2500-2503

2018

Link zum Volltext

Verfügbarkeit prüfen

Research developments in metabolism 2018

Metabolism, clinical and experimental, 2019-02, Vol.91, p.70-79

2019

Link zum Volltext

Verfügbarkeit prüfen

Treating prediabetes in the obese: are GLP-1 analogues the answer?

The Lancet (British edition), 2017-04, Vol.389 (10077), p.1371-1372

2017

Link zum Volltext

Verfügbarkeit prüfen

Metabolism updates: new directions, techniques, and exciting research that is broadening the horizons

Metabolism, clinical and experimental, 2020-01, Vol.102, p.154009, Article 154009

2020

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Leptin in Leanness and Obesity: JACC State-of-the-Art Review

The role of leptin in regulating bone metabolism

Pharmacotherapy of obesity: Available medications and drugs under investigation

Metabolic health and weight: Understanding metabolically unhealthy normal weight or metabolically healthy obese patients

Leptin alters energy intake and fat mass but not energy expenditure in lean subjects

Leptin and the brain: Influences on brain development, cognitive functioning and psychiatric disorders

Leptin applications in 2015: what have we learned about leptin and obesity?

Central nervous system regulation of eating: insights from human brain imaging

Acute diet soda consumption alters brain responses to food cues in humans: A randomized, controlled, cross-over pilot study

Fasting oxyntomodulin, glicentin, and gastric inhibitory polypeptide levels are associated with activation of reward‐ and attention‐related brain centres in response to visual food cues in adults with obesity: A cross‐sectional functional MRI study

GLP-1 receptors exist in the parietal cortex, hypothalamus and medulla of human brains and the GLP-1 analogue liraglutide alters brain activity related to highly desirable food cues in individuals with diabetes: a crossover, randomised, placebo-controlled trial

Decreased saliency processing as a neural measure of Barratt impulsivity in healthy adults

Leptin in congenital and HIV-associated lipodystrophy

Short-term treatment with high dose liraglutide improves lipid and lipoprotein profile and changes hormonal mediators of lipid metabolism in obese patients with no overt type 2 diabetes mellitus: a randomized, placebo-controlled, cross-over, double-blind clinical trial

Branched-Chain Amino Acids in relation to food preferences and insulin resistance in obese subjects consuming walnuts: A cross-over, randomized, double-blind, placebo-controlled inpatient physiology study

GEOFFREY HARRIS PRIZE LECTURE 2018: Novel pathways regulating neuroendocrine function, energy homeostasis and metabolism in humans

Old and new tools to study human brain physiology: Current state, future directions and implications for metabolic regulation

Of mice and men: incretin actions in the central nervous system

Short-term administration of the GLP-1 analog liraglutide decreases circulating leptin and increases GIP levels and these changes are associated with alterations in CNS responses to food cues: A randomized, placebo-controlled, crossover study

Lorcaserin treatment decreases body weight and reduces cardiometabolic risk factors in obese adults: A six‐month, randomized, placebo‐controlled, double‐blind clinical trial

Lorcaserin Administration Decreases Activation of Brain Centers in Response to Food Cues and These Emotion- and Salience-Related Changes Correlate With Weight Loss Effects: A 4-Week-Long Randomized, Placebo-Controlled, Double-Blind Clinical Trial

Obese individuals with type 2 diabetes demonstrate decreased activation of the salience‐related insula and increased activation of the emotion/salience‐related amygdala to visual food cues compared to non‐obese individuals with diabetes: A preliminary study

Research developments in metabolism 2018

Treating prediabetes in the obese: are GLP-1 analogues the answer?

Metabolism updates: new directions, techniques, and exciting research that is broadening the horizons

Suchergebnisse filtern